What is China Nucleic Acid Drug and Neotype Vaccine Industrial Conference?
A large number of new drug technologies have emerged in the field of biomedicine in recent years, and nucleic acid drugs are a pillar of the third revolution in biotechnology. According to statistics, more than 100 antibody drugs have been approved for marketing in the world, and many nucleic acid drugs are undergoing clinical trials or will be launched in the next few years. At the same time, with the advent of the post-epidemic era, the "big reshuffle" of the global vaccine industry is coming. Under the pressure of epidemic prevention, countries are actively seeking breakthroughs in various cutting-edge vaccine technologies, and the vaccine industry has become a rapidly developing industry. In particular, mRNA vaccines have shined in this epidemic, which has further promoted the development of the industry.
Committed to building a high-level professional exchange platform for pharmaceutical companies, biotechnology companies, scientific research institutions, technical service providers, investment institutions and other biopharmaceutical industry leaders and pathfinders working in the field of nucleic acid drugs and new vaccines, deepening Academic exchanges and industrialization cooperation, meeting the needs of upstream and downstream industry chains, promoting the research and development process of domestic nucleic acid drugs and new vaccines, and improving the technical level, China Nucleic Acid Drug and Neotype Vaccine Industrial Conference 2023 organized by Taas Labs will be held on June 15th- 16th in Wuhan, China. We sincerely invite you to visit us!
Agenda Highlights
Innovative GalNac Delivery Platform
Advances in R&D of Small Nucleic Acid Drugs in The Field of Cardiometabolic
RNA Activation Platform Technology for Rare Disease Drug Development
Functional Nucleic Acid Delivery System Based on Nucleic Acid Self-Assembly
Noncoding Nucleic Acids and Precision Medicine
Analysis and Strategy of Efficient and Long-Acting mRNA Delivery Technology
How to Design and Optimize the Production of Functional IVT mRNA?
R&D Progress of Peptide Vaccine
New Strategy for Developing Broad-Spectrum COVID-19 Vaccine
Cancer Vaccine Clinical Development Strategy
Speakers

Dr. Peter Zhang
Suzhou GenePharma Co., Ltd

Dr. Han Hu
Binhui Biopharm

Dr. Yunliang QIU
Innostar

Dr. Wenqiang YU
Institutes of Biomedical Sciences Fudan University

Prof. Jia FEI
Jinan University

Dr. Jinqiao WAN
Leaderna

Mrs. Sharon Tong
D-Nano Therapeutics

Dr. Robert J.Lee
Haichang Biotech

Dr. Yuanzheng QIU
CSPC

Dr. Libo ZHAO
Echo Biotech

Jiancun ZHANG
HNC

Dr. Frank GAO
BRL

Dr. Lei SUN
AbMax

Dr. Cheng ZHANG
TiPLab

Mr. Glenn HOU
China Insights Consultancy
Ways to Attend
Increase Your Visibility. Improve Your Reputation
Normal Ticket
1 Pass
2 Networking Buffet Lunch
Simultaneous Interpretation
PPTs & Documentation
Exhibition Sponsor
3 Passes
4㎡/6㎡/9㎡ Booth for show
Holistic Logo Branding On-site
2 Networking Buffet Lunch
Simultaneous Interpretation
PPTs& Documentation
Presentation Sponsor
5 Passes
30 min Speech Opportunity
1 Color AD Page
Panelist Discussion
Holistic Logo Branding On-site
2 Networking Buffet Lunch
Simultaneous Interpretation
PPTs& Documentation
Gold Sponsor
5 or More Passes
30 min Speech Opportunity
6㎡or 9㎡ Booth for show
Chairman Opportunity
1 Color AD Page
Panelist Discussion
Holistic Logo Branding On-site
2 Networking Buffet Lunch
Simultaneous Interpretation
PPTs& Documentation
Secure your ticket today
Early Bird tickets available now
Secure your spot with our special offer, and don’t go alone, enjoy the best group discount.
RegisterSponsors & Partners
Part of Media Partners



































